Home/Filings/4/0001209191-22-048528
4//SEC Filing

Williams Richard Thomas 4

Accession 0001209191-22-048528

CIK 0001797768other

Filed

Sep 1, 8:00 PM ET

Accepted

Sep 2, 5:00 PM ET

Size

5.1 KB

Accession

0001209191-22-048528

Insider Transaction Report

Form 4
Period: 2022-09-01
Williams Richard Thomas
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-09-01+25,00068,474 total
Footnotes (2)
  • [F1]The Issuer granted RSUs to the Reporting Person. Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer. A portion of the RSUs vest each quarter, subject to the Reporting Person's continued service as of each vesting date.
  • [F2]Includes 1,141 shares acquired under the Issuer's Employee Stock Purchase Plan in May 2022.

Issuer

Kinnate Biopharma Inc.

CIK 0001797768

Entity typeother

Related Parties

1
  • filerCIK 0001825148

Filing Metadata

Form type
4
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 5:00 PM ET
Size
5.1 KB